Lexicon Genetics Q3 Losses Narrow | GenomeWeb

NEW YORK, Oct 26 - Lexicon Genetics on Thursday reported third quarter net losses of $1.5 million, or three cents a share, including stock-based compensation charges for options granted to employees, compared with net losses of $3.8 million, or 10 cents a share, in the year ago period.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.